Combined discrete-event simulation and ant colony optimisation approach for selecting optimal screening policies for diabetic retinopathy

Computational Management Science

Volumn 4, Issue 1, 2007, Pages 59-83

  Brailsford, Sally C ^a   Gutjahr, Walter J ^b   Rauner, Marion S ^b   Zeppelzauer, Wolfgang ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ant colony optimisation; Cost effectiveness analysis; Decision support system; Discrete event simulation; Screening for diabetic retinopathy

Indexed keywords

EID: 33751010506     PISSN: 1619697X     EISSN: 16196988     Source Type: Journal    
DOI: 10.1007/s10287-006-0008-x     Document Type: Article

References (40)

1. Brailsford SC, Davies R (2001) Screening for diabetic retinopathy, www.management.soton.ac.uk/retinopathy, accessed 13 December 2005
2. Brailsford SC, Davies R, Canning C, Roderick PJ (1998) Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes. Health Care Manage Sci 1:115-124
3. British Multicentre Study Group (1975) Photocoagulation in treatment of diabetic maculopathy. The Lancet 2(7945):1110-1113
4. British Multicentre Study Group (1984) Photocoagulation for proliferative diabetic retinopathy: A randomised controlled trial using the xenon-arc. Diabetologia 26:109-115
5. Brown MB, Brown GC, Sharma S, Shah G (1999) Utility values and diabetic retinopathy. Am J Ophthalmol 128:324-330
6. Cooper K, Davies R, Roderick P, Chase D, Raftery J (2002) The development of a simulation model of the treatment of coronary heart disease. Health Care Manage Sci 5:259-67
7. Crijns H, Casparie AF, Hendrikse F (1999) Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy. Int J Technol Assess Health Care 15:198-206
8. Davies R, Brailsford SC (2004). Screening for diabetic retinopathy. In: Handbook of OR/MS applications in health care. Sainfort F, Brandeau M, Pierskalla W (Eds). International series in operations research and management science. Kluwer, Norwell Mass, pp. 493-518.
9. Davies R, Davies HTO (1994) Modelling patient flows and resource provision in health systems. Omega Int J Manage Sci 22:123-131
10. Davies HTO, Davies R (1995) Simulating health systems: Modelling problems and software solutions. Eur J Oper Res 87:35-44
11. Davies R, Brailsford SC, Roderick PJ, Canning C, Crabbe DN (2000) Using simulation modelling for evaluating screening services for diabetic retinopathy. J Oper Res Soc 51:476-484
12. Davies R, Roderick PJ, Canning C, Brailsford SC (2002) The evaluation of screening policies for diabetic retinopathy using simulation. Diabet Med 19:762-770
13. Department of Health (1991) The state of the nation. HMSO, London
14. Dorigo M, Di Caro G (1999). The ant colony optimisation metaheuristic. In: Corne D, Dorigo M, Glover F (eds). New ideas in optimisation. McGraw-Hill, New York, pp. 11-33
15. Dorigo M, Maniezzo V, Colorni A (1991) The ant system: An autocatalytic optimisation process. Technical Report 91-016, Department of Electronics Polytechnico di Milano, Italy
16. Dorigo M, Maniezzo V, Colorni A (1996) The ant system: Optimisation by a colony of cooperating agents. IEEE Trans Syst Man Cybern 26:1-13
17. Eastman RC, Javitt JC, Herman WC, Dasbach EJ, Zbrozek AS et al (1997a) Model of complications of NIDDM, I. Model construction and assumptions. Diabet Care 20:725-734
18. Eastman RC, Javitt JC, Herman WC, Dasbach EJ, Zbrozek AS et al (1997b) Model of complications of NIDDM II, analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycaemia. Diabet Care 20:735-744
19. Gutjahr WJ (2000) A graph-based Ant System and its convergence. Future Generation Comput Syst 16: 873-882
20. Gutjahr WJ (2003). A converging ACO algorithm for stochastic combinatorial optimisation. In: Albrecht A, Steinhöfl K (eds). Proceedings of SAGA 2003 (Stochastic Algorithms: Foundations and Applications). Springer, Berlin Heidelberg New York, pp. 10-25
21. Gutjahr WJ (2004). S-ACO: An ant-based approach to combinatorial optimisation under uncertainty. In: Dorigo, Birattari, Blum, Gambardelle, Mondada, Stützle (eds). Proceedings of ANTS 2004 (4th international workshop on ant colony optimisation and swarm intelligence. Brussels, Springer, Berlin Heidelberg New York, pp 238-249
22. Harper PR, Sayyad MG, De Senna V, Shahani A, Yajnik CS et al (2003) A systems modelling approach for the prevention and treatment of diabetic retinopathy. Eur J Oper Res 150:81-91
23. Hutchinson A, McIntosh A, Peters J, O'Keefe C, Khunti K et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy - systematic review. Diabetics 17:495-506
24. James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Bri Med J 320:627-1631
25. Javitt JC and Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Annals of Internal Medicine 124:164-169
26. Klein R, Moss SE, Klein BEK, Davies MD, De Mets LD (1989) The wisconsin epidemiologic study of diabetic retinopathy XI. The incidence of macular edema. Ophthalmology 96: 1501-1510
27. Lienert RT (1989) Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy. Aust NZ J Opththalmol 17:363-368
28. Liu WJ, Lee LT, Yen MF, Tung TH, Williams R et al (2003). Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: Implication for diabetic retinopathy screening in Taiwan. Diabet Med 20:727-733
29. Maberley D, Walker H, Koushik A, Cruess A (2003) Screening for diabetic retinopathy in James Bay, Ontario: A cost-effectiveness analysis. Can Med Assoc J 2:160-164
30. NHS Centre for Reviews and Dissemination (NHS CRD) (1999) Complications of diabetes: Screening for retinopathy. Management of foot ulcers. Effective Health Care Bulletin No. 5. University of York, UK
31. NHS NSC Diabetic Retinopathy Screening (2001) Resources for a national diabetic risk-reduction programme, www.diabetic-retinopathy.screening.nhs.uk/costings.html accessed 13 December 2005
32. Office of Population Censuses and Surveys (1992) Series DH1 No 24, Mortality statistics - general, HMSO, London
33. Polak BCP, Crijns H, Casparie AF, Niessen LW (2003) Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy. Health Policy 64:89-97
34. Pugh JA, Jacobson JM, Van Heuven WA et al (1993) Screening for diabetic retinopathy. The wide angle retinal camera. Diabet Care 16:889-895
35. Rauner MS, Brailsford SC, Flessa S (2005a) The use of discrete-event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries. J Oper Res Soc 56:222-233
36. Rauner MS, Gutjahr WJ, Brailsford SC and Zeppelzauer W (2005b) Optimal screening policies for diabetic retinopathy using a combined discrete-event simulation and ant colony optimization approach. In: Anderson JG, Katzper M (eds) Proceedings of the 2005 international conference on health sciences simulation, Western simulation multiconference 2005, 23-27 January 2005, New Orleans, The Society for Modeling and Simulation International, San Diego pp 147-152
37. Reenders K, de Noble E, van den Hoogen H, van Weel C (1992) Screening for diabetic retinopathy by general practitioners. Scand J Prim Health Care 10:306-309
38. Samanta A, Burden ACm, Fent B (1987) Comparative prevalence of NIDDM in Asian and white Caucasian adults. Diabet Res Clin Pract 4:1-6
39. Torrance GW, Feeny D (1989) Utilities and quality adjusted life years. Int J Technol Assess Health Care 2:559-575
40. Vijan S, Hofer TP, Hayward RA (2000) Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. J Am Med Assoc 283:889-96